Award-winning Porterhouse Medical Group joins UK-headquartered, global healthcare communications company imc group, backed by Waterland Private Equity (Waterland), in the first step of its ambitious plans to create an independent provider of global healthcare communications and consulting services to the pharmaceutical and biotech industries.
Award-winning Porterhouse Medical Group joins UK-headquartered, global healthcare communications company imc group, backed by Waterland Private Equity (Waterland), in the first step of its ambitious plans to create an independent provider of global healthcare communications and consulting services to the pharmaceutical and biotech industries.Porterhouse Medical Group, comprising Porterhouse Medical, Porterhouse Medical US and Porterhouse Insights, specialises in strategic medical communications, publication planning and insights research. The company, winner of the Queens Award for Enterprise and Investors in People Gold, employs 65 people from its UK base in Reading with offices in Nottingham (UK) and Philadelphia (US).
Porterhouse Medical Group will bolster imc group’s already extensive service proposition with additional capabilities within publications planning and insights research. Porterhouse shares imc group’s philosophy that clients require strategic and data-led solutions, capitalising on multidisciplinary teams to deliver the best results.
Shairose Ebrahim, Co-Founder, President and CEO of imc group, says: “I am delighted to welcome the Porterhouse team to imc group. Bringing these two talented healthcare communicators together will ensure that we can continue the important work our industry does to provide clarity and insight across all stages of the drug development process, with the ultimate aim of improving patient outcomes.”
Jon Hallows, Co-Founder and Joint MD of Porterhouse Medical Group, adds: “imc group and Waterland Private Equity are the natural partners for the next stage of Porterhouse’s development. By combining forces, we can deliver an innovative, joined-up, world-class service to our clients during an unprecedented period for the industry we serve.” Co-Founder Brian Parsons added: “The tie up is great news for our employees who, in time, will have an opportunity to work in a broader range of therapy areas and project types.”
Dominic Graham, Senior Investment Manager at Waterland Private Equity, adds: “We are excited to welcome Jon, Brian, Fabrice, Gordon and their dedicated team at Porterhouse to the imc group. The experience has been very positive, demonstrating our people-centric approach and sets the benchmark for what other businesses can expect when choosing to partner with imc group. We aspire to be the partner of choice for pharmaceutical and biotech communications, digital and consulting companies looking to become part of a larger independent group”.
The transaction was supported by credit fund, LGT Private Debt. imc group was advised by: PwC (Financial and Tax), Candesic (Commercial), DWF (Legal), Clearwater International (Debt Advisory).
